Effect Of Prognostic Noninvasive Tests On Disease Outcome Of Alcohol-Related Liver Disease
Zeitschrift für Gastroenterologie · 01.01.2023 · 61 (01) · e29-e30
DOI: 10.1055/s-0042-1759989 ↗Kurz gefasst
Fachartikel in der Zeitschrift Zeitschrift für Gastroenterologie, erschienen am 01.01.2023. Verfasst von Burak Alper Zengin und 11 weiteren Autor:innen.
Abstract (Originalsprache)
Aims
The aims of the study were to determine the characteristics of patients with alcohol-related liver disease (ALD) and to identify whether the factors affect the course of disease.
Methods
Between 01/2001–12/2021, 187 patients, who were diagnosed with ALD were included. FIB-4, NFS, Forns, APRI and AST/ALT were calculated. Data were collected from outpatient visit charts.
Results
All 187 patients were Caucasian, mean age was 51,6±10,1 years, and gender was predominantly male (98%). At diagnosis, 59 patients had hepatosteatosis/steatohepatitis and 128 patients had cirrhosis, 43,8% of them were decompensated: 15% of the patients were classified as having Child-Pugh A, 56% Child-Pugh B, 29% Child-Pugh C. Median MELD score was 14 (range: 7−33). Ascites (71%) was the most common causes of decompensation, followed by variceal bleeding (18%), and hepatic encephalopathy (11%). Ten patients (8%) were diagnosed with HCC. The mean FIB-4, NFS, Forns, APRI and AST/ALT were 3,22±2,99 (median: 2,28), −0,86±2,9 (median: −1,26), 5,95±2,6 (median: 5,8), 1,17±1,34 (median: 0,71) and 1,51±1,0 (median 1,2) respectively. The scores of noninvasive tests were significantly higher in cirrhotic patients (p>0,001). During a median follow-up of 32.6 months, cirrhosis was developed in 20% of noncirrhotic patients, decompensation was developed in 79% of compensated cirrhotic patients. HCC was developed in 7 cirrhotic patients. Twenty-one patients (11%) underwent transplantation, and 72 (39%) patients died. The FIB-4, NFS, Forns and APRI were significantly higher in transplanted and non-survival patients (p
Zitieren
APA
Zengin, B. A., Gümüşsoy, M., Duman, S., Bodakçı, E., Ellik, Z., Ozercan, M., Erdem, E. R., Karakaya, F., Guvenir, S. T., Gökcan, H., Ilhan, İ., & İdilman, R. (2023). Effect Of Prognostic Noninvasive Tests On Disease Outcome Of Alcohol-Related Liver Disease. Zeitschrift für Gastroenterologie, 61(01), e29-e30. https://doi.org/10.1055/s-0042-1759989
Vancouver
Zengin BA, Gümüşsoy M, Duman S, Bodakçı E, Ellik Z, Ozercan M, et al. Effect Of Prognostic Noninvasive Tests On Disease Outcome Of Alcohol-Related Liver Disease. Zeitschrift für Gastroenterologie. 2023;61(01):e29-e30. doi:10.1055/s-0042-1759989
BibTeX
@article{Zengin2023,
author = {Zengin, Burak Alper and Gümüşsoy, Mesut and Duman, Serkan and Bodakçı, Emin and Ellik, Zeynep and Ozercan, Mubin and Erdem, E R and Karakaya, Fatih and Guvenir, Sevinc Tugce and Gökcan, Hale and Ilhan, İnci and İdilman, Ramazan},
title = {Effect Of Prognostic Noninvasive Tests On Disease Outcome Of Alcohol-Related Liver Disease},
journal = {Zeitschrift für Gastroenterologie},
year = {2023},
volume = {61},
number = {01},
pages = {e29--e30},
doi = {10.1055/s-0042-1759989}
}
EUVIMED